AXA S.A. increased its stake in shares of The Allstate Co. (NYSE:ALL - Free Report) by 85.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,470 shares of the insurance provider's stock after acquiring an additional 15,415 shares during the quarter. AXA S.A.'s holdings in Allstate were worth $6,453,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Apella Capital LLC grew its stake in Allstate by 1.9% during the 4th quarter. Apella Capital LLC now owns 3,231 shares of the insurance provider's stock worth $623,000 after buying an additional 60 shares during the last quarter. Intrust Bank NA raised its position in Allstate by 0.5% in the 4th quarter. Intrust Bank NA now owns 12,135 shares of the insurance provider's stock valued at $2,340,000 after purchasing an additional 61 shares during the last quarter. Perigon Wealth Management LLC boosted its stake in Allstate by 2.1% during the 4th quarter. Perigon Wealth Management LLC now owns 2,990 shares of the insurance provider's stock worth $571,000 after purchasing an additional 62 shares during the period. Mather Group LLC. grew its position in Allstate by 1.7% during the 4th quarter. Mather Group LLC. now owns 3,616 shares of the insurance provider's stock worth $697,000 after purchasing an additional 62 shares during the last quarter. Finally, Angeles Wealth Management LLC raised its holdings in shares of Allstate by 4.6% in the fourth quarter. Angeles Wealth Management LLC now owns 1,403 shares of the insurance provider's stock valued at $270,000 after buying an additional 62 shares during the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have commented on ALL shares. JPMorgan Chase & Co. upped their price objective on Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Evercore ISI lifted their price objective on shares of Allstate from $227.00 to $230.00 and gave the company an "outperform" rating in a research report on Thursday, May 1st. Argus upgraded shares of Allstate from a "hold" rating to a "buy" rating in a research report on Monday, March 3rd. Morgan Stanley boosted their price target on shares of Allstate from $225.00 to $235.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 6th. Finally, Wells Fargo & Company reduced their price objective on shares of Allstate from $200.00 to $197.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. One research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Allstate presently has an average rating of "Moderate Buy" and a consensus price target of $225.20.
Get Our Latest Analysis on ALL
Allstate Trading Down 0.0 %
Shares of Allstate stock traded down $0.05 during trading hours on Friday, reaching $202.57. 707,236 shares of the company's stock were exchanged, compared to its average volume of 1,616,559. The firm has a market capitalization of $53.64 billion, a price-to-earnings ratio of 11.92, a price-to-earnings-growth ratio of 1.01 and a beta of 0.32. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42. The Allstate Co. has a 52-week low of $156.66 and a 52-week high of $212.91. The company has a fifty day moving average of $199.06 and a 200-day moving average of $195.17.
Allstate (NYSE:ALL - Get Free Report) last issued its earnings results on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share for the quarter, missing the consensus estimate of $3.98 by ($0.45). Allstate had a return on equity of 28.20% and a net margin of 7.28%. The firm had revenue of $14.30 billion during the quarter, compared to analysts' expectations of $16.41 billion. During the same period last year, the business posted $5.13 earnings per share. The company's quarterly revenue was up 7.8% compared to the same quarter last year. Sell-side analysts forecast that The Allstate Co. will post 18.74 EPS for the current fiscal year.
Allstate Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 10th were given a dividend of $1.00 per share. The ex-dividend date of this dividend was Monday, March 10th. This is a positive change from Allstate's previous quarterly dividend of $0.92. This represents a $4.00 annualized dividend and a yield of 1.97%. Allstate's payout ratio is 27.32%.
Allstate announced that its Board of Directors has initiated a share repurchase program on Wednesday, February 26th that authorizes the company to repurchase $1.50 billion in shares. This repurchase authorization authorizes the insurance provider to buy up to 3% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's management believes its shares are undervalued.
Insider Activity at Allstate
In related news, CFO Jesse E. Merten sold 40,102 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the transaction, the chief financial officer now owns 18,115 shares of the company's stock, valued at approximately $3,378,990.95. This represents a 68.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 1.80% of the company's stock.
About Allstate
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories

Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.